Remedent, Inc. (REMI)
OTCMKTS · Delayed Price · Currency is USD
0.0007
+0.0001 (16.67%)
At close: Jan 30, 2026

Remedent Cash Flow Statement

Millions EUR. Fiscal year is Apr - Mar.
Fiscal Year
FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Mar '23 Mar '22 Mar '21 Mar '20 Mar '19 2018 - 2014
Net Income
----1.9
Upgrade
Depreciation & Amortization
----0.09
Upgrade
Loss (Gain) on Equity Investments
-----2.54
Upgrade
Provision & Write-off of Bad Debts
-----0.03
Upgrade
Other Operating Activities
-----0.06
Upgrade
Change in Accounts Receivable
----0.82
Upgrade
Change in Inventory
----0.01
Upgrade
Change in Accounts Payable
----0.31
Upgrade
Change in Unearned Revenue
-----0.02
Upgrade
Change in Other Net Operating Assets
----0.02
Upgrade
Operating Cash Flow
----0.51
Upgrade
Operating Cash Flow Growth
----2965.32%
Upgrade
Foreign Exchange Rate Adjustments
-----0.53
Upgrade
Net Cash Flow
-----0.02
Upgrade
Free Cash Flow
----0.51
Upgrade
Free Cash Flow Growth
----3829.67%
Upgrade
Free Cash Flow Margin
----35.39%
Upgrade
Free Cash Flow Per Share
----0.03
Upgrade
Cash Interest Paid
----0.01
Upgrade
Levered Free Cash Flow
----0.88
Upgrade
Unlevered Free Cash Flow
----0.89
Upgrade
Change in Working Capital
----1.15
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.